Loading...

Abiomed, Inc.

0H7S.LLSE
Healthcare
Medical - Equipment & Services
£381.02
£0.29(0.08%)

Abiomed, Inc. (0H7S.L) Stock Competitors & Peer Comparison

See (0H7S.L) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Equipment & Services Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
0H7S.L£381.02+0.08%0N/AN/AN/A
0R29.L£477.94-1.77%172B106.84£4.49N/A
0HOY.L£104.79-1.63%156.2B199.16£0.53N/A
0R2S.L£373.69-6.93%142.8B71.06£5.26+0.88%
0R2B.L£195.43-2.51%140.1B22.65£8.64+0.60%
0Y6X.L£89.34-2.03%114.5B23.95£3.73+3.15%
0JZU.L£695.07-1.79%86.8B96.16£7.23+0.41%
0J1R.L£355.74-0.26%85.6B16.71£21.29+0.77%
0HRS.L£61.93-0.91%78B10.25£6.01+4.28%
0HG8.L£281.88-3.98%64.2B11.22£25.40+2.43%
Showing 1 to 10 of 60 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

0H7S.L vs 0R29.L Comparison August 2025

0H7S.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 0H7S.L stands at 0. In comparison, 0R29.L has a market cap of 172B. Regarding current trading prices, 0H7S.L is priced at £381.02, while 0R29.L trades at £477.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

0H7S.L currently has a P/E ratio of N/A, whereas 0R29.L's P/E ratio is 106.84. In terms of profitability, 0H7S.L's ROE is N/A, compared to 0R29.L's ROE of +0.16%. Regarding short-term risk, Volatility data is not available for a full comparison. 0H7S.L has daily volatility of N/A and 0R29.L has daily volatility of 2.60.Check 0R29.L's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;